Učitavanje...
Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis
Drug-induced Immune Haemolytic Anaemia (DIIHA) is a rare but serious complication of cephalosporin use. Ceftazidime is recognized to be a rare cause of DIIHA. We report and discuss a case of DIIHA in a person with cystic fibrosis who developed severe haemolytic anaemia following use of ceftazidime i...
Spremljeno u:
| Izdano u: | F1000Res |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
F1000 Research Limited
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5920311/ https://ncbi.nlm.nih.gov/pubmed/29770214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.14505.1 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|